The CapitalBiotech® BioelectronSeq 4000 Sequencer uses semiconductor chip sequencing technology together with compatible clinical testing kits and automated analysis softwares to support in-house genetic testing workflows in hospitals and medical laboratories. During sequencing, base incorporation is detected in real time by measuring pH changes associated with hydrogen ion (H⁺) release during DNA synthesis.